ALKAMI TECHNOLOGY, INC.
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
ALKT$14.16-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
| Nine months ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net loss | $(25,608) | $(36,211) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depreciation and amortization expense | 24,725 | 19,055 |
| Accrued interest on marketable securities, net | (93) | (667) |
| Stock-based compensation expense | 54,029 | 56,336 |
| Amortization of discount and debt issuance costs | 1,711 | 1,367 |
| Loss on impairment of intangible assets | — | 1,655 |
| Deferred taxes | 228 | (11,971) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (10,016) | (10,457) |
| Prepaid expenses and other assets | (987) | (5,882) |
| Accounts payable and accrued liabilities | 125 | 14,424 |
| Deferred costs | (5,389) | (6,538) |
| Deferred revenues | 406 | 5,189 |
| Net cash provided by operating activities | 39,131 | 26,300 |
| Cash flows from investing activities: | ||
| Purchase of marketable securities | (29,178) | (35,854) |
| Proceeds from sales, maturities, and redemptions of marketable securities | 29,998 | 24,300 |
| Purchases of property and equipment | (1,276) | (1,156) |
| Capitalized software development costs | (5,432) | (5,255) |
| Acquisition of business, net of cash acquired | — | (375,499) |
| Net cash used in investing activities | (5,888) | (393,464) |
| Cash flows from financing activities: | ||
| Payments on revolving loan | (15,000) | (35,000) |
| Debt issuance costs paid | — | (1,898) |
| Proceeds from ESPP issuances | 3,094 | 2,943 |
| Proceeds from issuance of convertible senior notes | — | 335,513 |
| Proceeds from borrowing under revolving loan | — | 60,000 |
| Purchase of capped calls | — | (33,879) |
| Payments for taxes related to net settlement of equity awards | (11,236) | — |
| Proceeds from stock option exercises | 1,762 | 2,442 |
| Repurchases of common stock | (25,000) | — |
| Net cash (used in) provided by financing activities | (46,380) | 330,121 |
| Net decrease in cash and cash equivalents | (13,137) | (37,043) |
| Cash and cash equivalents, beginning of period | 63,457 | 94,359 |
| Cash and cash equivalents, end of period | $50,320 | $57,316 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.